IOVA

Iovance Biotherapeutics Inc [IOVA] Revenue clocked in at $241.53 million, down -77.36% YTD: What’s Next?

Edison Baldwin

Iovance Biotherapeutics Inc [NASDAQ: IOVA] loss -5.56% on the last trading session, reaching $2.21 price per share at the time. ...

why Iovance Biotherapeutics Inc [IOVA] is a Good Choice for Investors After New Price Target of $9.10

Edison Baldwin

Iovance Biotherapeutics Inc [NASDAQ: IOVA] loss -2.36% or -0.05 points to close at $2.07 with a heavy trading volume of ...

Market Analysts see Iovance Biotherapeutics Inc [IOVA] gaining to $1. Time to buy?

Misty Lee

Iovance Biotherapeutics Inc [NASDAQ: IOVA] closed the trading session at $2.3 on 2025-09-16. The day’s price range saw the stock ...

DBT News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.